Orange Book product · Generic (ANDA)
LINCOMYCIN HYDROCHLORIDE
LINCOMYCIN HYDROCHLORIDE
At a glance
Apr 16, 1991
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 16, 1991
35 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
LINCOMYCIN HYDROCHLORIDE
Strength
EQ 300MG BASE/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 063180
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LINCOMYCIN HYDROCHLORIDE
- —LINCOCINBrand (NDA)
NDA 050316 · PHARMACIA AND UPJOHN
- —LINCOCINBrand (NDA)
NDA 050317 · PFIZER
- 2022LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 216662 · SLATE RUN PHARMA
- 2022LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215657 · GLAND
- 2021LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215082 · MICRO LABS
- 2021LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 212770 · ARTHUR GRP
- 2015LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 201746 · XGEN PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
